Members of the Alabama Medical Cannabis Commission gave out 21 business licenses on Monday.
Applicants awarded a license will have 14 days to submit the appropriate license fee to the Commission. At its meeting on July 10, 2023, the Commission is scheduled to issue licenses in each license category. The annual license fees range from $30,000 to $50,000, depending on the type.
The following licenses were awarded:
Integrated Facility Licenses:
Flowerwood Medical Cannabis, LLC
Southeast Cannabis Company, LLC
Sustainable Alabama, LLC
TheraTrue Alabama, LLC
Verano Alabama, LLC
Cultivator Licenses:
Blackberry Farms, LLC
Gulf Shore Remedies, LLC
Pure by Sirmon Farms, LLC
Twisted Herb Cultivation, LLC
Processor Licenses:
1819 Labs, LLC
Enchanted Green, LLC
Jasper Development Group Inc.
Organic Harvest Lab, LLC
Dispensary Licenses:
CCS of Alabama, LLC
RJK Holdings, LLC
Statewide Property Holdings AL, LLC
Yellowhammer Medical Dispensaries, LLC
Alabama Secure Transport, LLC
International Communication, LLC
Tyler Van Lines, LLC
Certus Laboratories
The businesses were selected from about 90 applicants accepted by the commission in April.
Under the rules promulgated by the Alabama Board of Medical Examiners, physicians may begin the certification process to recommend medical cannabis after business licenses have been issued. For a patient to qualify for medical cannabis, the patient must have at least one of the qualifying conditions and be recommended for medical cannabis by a certified physician.
Commission members are appointed to the commission for established terms by various appointing authorities, including the Governor, Lieutenant Governor, President Pro Tempore of the Senate, Speaker of the House of Representatives, Commissioner of Agriculture and Industries, State Health Officer, Attorney General, and Secretary of the Alabama State Law Enforcement Agency.
Members of the Commission include: Dr. William Saliski, Pulmonologist; Dr. Sam Blakemore, Pharmacist; Dwight Gamble, Banker; Dr. Angela Martin, Pediatrician; Dr. Eric Jensen, Biochemist; Loree Skelton, Attorney; Rex Vaughn, Farmer; Judge Charles Price, Circuit Judge; Dr. Steven Stokes, Oncologist; Taylor Hatchett, Farmer; James Harwell, Nurseryman and Landscaper, Dr. Jerzy Szflarski, Neurologist, and Dion Robinson, Department of Corrections.
Under Alabama's program, registered certifying physicians may recommend medical cannabis to patients who have been diagnosed with autism spectrum disorder; cancer-related pain or nausea; Crohn's Disease; depression; epilepsy or conditions causing seizures; HIV/AIDS-related nausea or weight loss; panic disorder; Parkinson's Disease; persistent nausea; post-traumatic stress disorder (PTSD); sickle cell anemia; spasticity associated with multiple sclerosis or spinal cord injury; Tourette's Syndrome; a terminal illness; or conditions causing chronic or intractable pain.
Medical cannabis products that may be recommended to patients include tablets, capsules, tinctures, gelatinous cubes, gels, oils or creams for topical use, suppositories, transdermal patches, nebulizers, or liquids or oils for use in an inhaler. Raw plant materials, products administered by smoking or vaping, or food products such as cookies or candies are not allowed.
Don't miss out! Subscribe to our newsletter and get our top stories every weekday morning.
